scholarly journals P14.20 Multi-Spectral Imaging of Lung Adenocarcinoma Reveals Importance of Cancer Specific HLA-DR on the TME and Clinical Outcome

2021 ◽  
Vol 16 (3) ◽  
pp. S338
Author(s):  
A. Johnson ◽  
E. Klezcko ◽  
R. Nemenoff ◽  
E. Schenk
Keyword(s):  
Clinical Outcome ◽  
Lung Adenocarcinoma ◽  
Spectral Imaging ◽  
Hla Dr

scholarly journals Analysis of ultra-deep targeted sequencing reveals mutation burden is associated with gender and clinical outcome in lung adenocarcinoma

Oncotarget ◽  
2016 ◽  
Vol 7 (16) ◽  
pp. 22857-22864 ◽  
Author(s):  
Dakai Xiao ◽  
Hui Pan ◽  
Fuqiang Li ◽  
Kui Wu ◽  
Xin Zhang ◽  
...  
Keyword(s):  
Clinical Outcome ◽  
Lung Adenocarcinoma ◽  
Targeted Sequencing ◽  
Mutation Burden

scholarly journals Mutational monitoring of EGFR T790M in cfDNA for clinical outcome prediction in EGFR-mutant lung adenocarcinoma

PLoS ONE ◽  
2018 ◽  
Vol 13 (11) ◽  
pp. e0207001 ◽  
Author(s):  
Kang-Yi Su ◽  
Jeng-Sen Tseng ◽  
Keng-Mao Liao ◽  
Tsung-Ying Yang ◽  
Kun-Chieh Chen ◽  
...  
Keyword(s):  
Clinical Outcome ◽  
Lung Adenocarcinoma ◽  
Outcome Prediction ◽  
Clinical Outcome Prediction ◽  
Egfr Mutant ◽  
Egfr T790m

scholarly journals Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma

2020 ◽  
Vol 9 (24) ◽  
pp. 9581-9594
Author(s):  
Linzhi Han ◽  
Hongjie Shi ◽  
Yuan Luo ◽  
Wenjie Sun ◽  
Shuying Li ◽  
...  
Keyword(s):  
Clinical Outcome ◽  
Lung Adenocarcinoma ◽  
B Cell ◽  
Gene Signature

scholarly journals Pathway-based gene signatures predicting clinical outcome of lung adenocarcinoma

2015 ◽  
Vol 5 (1) ◽  
Author(s):  
Ya-Hsuan Chang ◽  
Chung-Ming Chen ◽  
Hsuan-Yu Chen ◽  
Pan-Chyr Yang
Keyword(s):  
Clinical Outcome ◽  
Lung Adenocarcinoma ◽  
Gene Signatures

scholarly journals Deubiquitinase UCHL5 is elevated and associated with a poor clinical outcome in lung adenocarcinoma (LUAD)

2020 ◽  
Vol 11 (22) ◽  
pp. 6675-6685
Author(s):  
Jieru Zhang ◽  
Hui Xu ◽  
Xiaomei Yang ◽  
Yuanjie Zhao ◽  
Xinchun Xu ◽  
...  
Keyword(s):  
Clinical Outcome ◽  
Lung Adenocarcinoma ◽  
Poor Clinical Outcome

scholarly journals Claudin-1 Is a Metastasis Suppressor and Correlates with Clinical Outcome in Lung Adenocarcinoma

2009 ◽  
Vol 179 (2) ◽  
pp. 123-133 ◽  
Author(s):  
Yu-Chih Chao ◽  
Szu-Hua Pan ◽  
Shuenn-Chen Yang ◽  
Sung-Liang Yu ◽  
Ting-Fang Che ◽  
...  
Keyword(s):  
Clinical Outcome ◽  
Lung Adenocarcinoma ◽  
Metastasis Suppressor

scholarly journals The Tissue Microlocalisation and Cellular Expression of CD163, VEGF, HLA-DR, iNOS, and MRP 8/14 Is Correlated to Clinical Outcome in NSCLC

PLoS ONE ◽  
2011 ◽  
Vol 6 (7) ◽  
pp. e21874 ◽  
Author(s):  
Chandra M. Ohri ◽  
Aarti Shikotra ◽  
Ruth H. Green ◽  
David A. Waller ◽  
Peter Bradding
Keyword(s):  
Clinical Outcome ◽  
Cellular Expression ◽  
Hla Dr

Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient

1990 ◽  
Vol 77 (2) ◽  
pp. 204-207 ◽  
Author(s):  
M. J. Hershman ◽  
W. G. Cheadle ◽  
S. R. Wellhausen ◽  
P. F. Davidson ◽  
H. C. Polk
Keyword(s):  
Clinical Outcome ◽  
Trauma Patient ◽  
Antigen Expression ◽  
Hla Dr

scholarly journals CompoundEGFRmutation is frequently detected with co-mutations of actionable genes and associated with poor clinical outcome in lung adenocarcinoma

2016 ◽  
Vol 17 (3) ◽  
pp. 237-245 ◽  
Author(s):  
Eun Young Kim ◽  
Eun Na Cho ◽  
Heae Surng Park ◽  
Ji Young Hong ◽  
Seri Lim ◽  
...  
Keyword(s):  
Clinical Outcome ◽  
Lung Adenocarcinoma ◽  
Poor Clinical Outcome
Sign in / Sign up

Export Citation Format

Share Document